16:26 EDT Adial Pharmaceuticals files to sell 2.37M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADIL:
- Adial Pharmaceuticals up 109% at $2.36 after disclosing results from AD04 trial
- Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
- Adial Pharmaceuticals announces results from trial of AD04
- Adial Pharma’s Cybersecurity Challenge: Navigating the Risks of IT Dependence in Data Management
- Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update